Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the CNS. 1 In early disease, active bouts of demyelination are followed by periods of remission, and relapses are ...

Mechanisms of Multiple Sclerosis. The pathogenesis of MS involves the initiation and perpetuation of inflammatory mediators, which leads to apoptosis of oligodendrocytes and damage to the myelin ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Although the basic pathology of MS was already recognized in the 18th century, its causes and pathogenesis remain elusive. The most widely accepted theory is that MS develops in genetically ...

Multiple sclerosis (MS) is a common immune-mediated progressive neurodegenerative disease of the CNS that typically manifests with periods of disease activity followed by intervals of remission ...

Epstein-Barr Virus. Epstein-Barr virus (EBV) has long been postulated to play a role in the pathogenesis of MS, but that connection received a solid boost in 2022, when Alberto Ascherio, MD, DrPH ...

Multiple sclerosis (MS) is a chronic debilitating inflammatory disease targeting the brain. The pathogenesis of MS remains largely unknown, though brain tissue damage in MS is likely due to immune ...

“Multiple sclerosis (MS) ... “While progress has been made in defining the immune system’s role in MS pathophysiology, the contribution of intrinsic CNS cell dysfunction remains unclear. ...

In fact, a study of 801 MS cases from more than 10 million active-duty military personnel over 20 years found that EBV ...

Following a competitive selection process, Ashlyn Anderson was chosen as the recipient of the inaugural Tanner MS Scholar Award. Ashlyn is a 4 th year PhD student at the University of Alabama at ...